The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment
Authors
Keywords
precision oncology, precision medicine, molecular medicine, cancer diagnosis, cancer treatment, clinical trial, genomics, proteomics, proteogenomics, targeted therapy, collaboration, data sharing, open access
Journal
CELL
Volume 184, Issue 7, Pages 1661-1670
Publisher
Elsevier BV
Online
2021-04-02
DOI
10.1016/j.cell.2021.02.055
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma
- (2021) Chen Huang et al. CANCER CELL
- Proteogenomic Characterization of Endometrial Carcinoma
- (2020) Yongchao Dou et al. CELL
- THE MOLECULAR ANALYSIS FOR THERAPY CHOICE (NCI-MATCH) TRIAL: LESSONS for GENOMIC TRIAL DESIGN
- (2020) Keith T Flaherty et al. JNCI-Journal of the National Cancer Institute
- An improved Boosting to Amplify Signal with Isobaric Labeling (iBASIL) strategy for precise quantitative single-cell proteomics
- (2020) Chia-Feng Tsai et al. MOLECULAR & CELLULAR PROTEOMICS
- Microscaled proteogenomic methods for precision oncology
- (2020) Shankha Satpathy et al. Nature Communications
- Cancer neoantigen prioritization through sensitive and reliable proteogenomics analysis
- (2020) Bo Wen et al. Nature Communications
- Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society
- (2020) Elizabeth T. H. Fontham et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma
- (2020) Michael A. Gillette et al. CELL
- Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression
- (2020) Yi-Ju Chen et al. CELL
- The Effect of Advances in Lung-Cancer Treatment on Population Mortality
- (2020) Nadia Howlader et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer
- (2020) Francesca Petralia et al. CELL
- Proteogenomic Characterization of Human Early-Onset Gastric Cancer
- (2019) Dong-Gi Mun et al. CANCER CELL
- Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities
- (2019) Suhas Vasaikar et al. CELL
- Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial
- (2019) Jordi Rodon et al. NATURE MEDICINE
- Declines in Vaccine-Type Human Papillomavirus Prevalence in Females Across Racial/Ethnic Groups: Data From a National Survey
- (2019) Nancy M. McClung et al. JOURNAL OF ADOLESCENT HEALTH
- Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
- (2019) Qiang Gao et al. CELL
- Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
- (2019) David J. Clark et al. CELL
- Genomics and the History of Precision Oncology
- (2019) Deborah B. Doroshow et al. Surgical Oncology Clinics of North America
- SnapShot: TCGA-Analyzed Tumors
- (2018) Amy Blum et al. CELL
- Revolutionizing Precision Oncology through Collaborative Proteogenomics and Data Sharing
- (2018) Henry Rodriguez et al. CELL
- pRAD50: a novel and clinically applicable pharmacodynamic biomarker of both ATM and ATR inhibition identified using mass spectrometry and immunohistochemistry
- (2018) Gemma N. Jones et al. BRITISH JOURNAL OF CANCER
- Clinical potential of mass spectrometry-based proteogenomics
- (2018) Bing Zhang et al. Nature Reviews Clinical Oncology
- The evidence framework for precision cancer medicine
- (2017) Jeffrey A. Moscow et al. Nature Reviews Clinical Oncology
- Precision medicine needs randomized clinical trials
- (2017) Everardo D. Saad et al. Nature Reviews Clinical Oncology
- APOBEC3A is an oral cancer prognostic biomarker in Taiwanese carriers of an APOBEC deletion polymorphism
- (2017) Ting-Wen Chen et al. Nature Communications
- Announcing cIMPACT-NOW: the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
- (2016) Hui Zhang et al. CELL
- Proteogenomics connects somatic mutations to signalling in breast cancer
- (2016) Philipp Mertins et al. NATURE
- Toward a Shared Vision for Cancer Genomic Data
- (2016) Robert L. Grossman et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Mass Spectrometry–Based Assay for the Accurate Measurement of Thyroglobulin From Patient Samples Containing Antithyroglobulin Autoantibodies
- (2016) Nigel J. Clarke et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
- (2015) Christophe Le Tourneau et al. LANCET ONCOLOGY
- Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
- (2015) David M. Hyman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- A New Initiative on Precision Medicine
- (2015) Francis S. Collins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Usefulness of a Thyroglobulin Liquid Chromatography-Tandem Mass Spectrometry Assay for Evaluation of Suspected Heterophile Interference
- (2014) B. C. Netzel et al. CLINICAL CHEMISTRY
- Ischemia in Tumors Induces Early and Sustained Phosphorylation Changes in Stress Kinase Pathways but Does Not Affect Global Protein Levels
- (2014) Philipp Mertins et al. MOLECULAR & CELLULAR PROTEOMICS
- Targeted Peptide Measurements in Biology and Medicine: Best Practices for Mass Spectrometry-based Assay Development Using a Fit-for-Purpose Approach
- (2014) Steven A. Carr et al. MOLECULAR & CELLULAR PROTEOMICS
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Proteogenomic characterization of human colon and rectal cancer
- (2014) Bing Zhang et al. NATURE
- CPTAC Assay Portal: a repository of targeted proteomic assays
- (2014) Jeffrey R Whiteaker et al. NATURE METHODS
- Measurement of Thyroglobulin by Liquid Chromatography-Tandem Mass Spectrometry in Serum and Plasma in the Presence of Antithyroglobulin Autoantibodies
- (2013) M. M. Kushnir et al. CLINICAL CHEMISTRY
- Improving the Measurement of Serum Thyroglobulin With Mass Spectrometry
- (2013) Andrew N. Hoofnagle et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- Tumour heterogeneity in the clinic
- (2013) Philippe L. Bedard et al. NATURE
- Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins
- (2013) Jacob J Kennedy et al. NATURE METHODS
- BRAF mutations in melanoma and colorectal cancer: A single oncogenic mutation with different tumour phenotypes and clinical implications
- (2012) F. Sclafani et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry
- (2012) Michael A Gillette et al. NATURE METHODS
- Proteomics meets the scientific method
- (2012) Paola Picotti et al. NATURE METHODS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The evolving role of mass spectrometry in cancer biomarker discovery
- (2010) Pei Wang et al. CANCER BIOLOGY & THERAPY
- A Multi-Level Systems Perspective for the Science of Team Science
- (2010) K. Borner et al. Science Translational Medicine
- Protein-Based Multiplex Assays: Mock Presubmissions to the US Food and Drug Administration
- (2009) F. E. Regnier et al. CLINICAL CHEMISTRY
- Analytical Validation of Protein-Based Multiplex Assays: A Workshop Report by the NCI-FDA Interagency Oncology Task Force on Molecular Diagnostics
- (2009) H. Rodriguez et al. CLINICAL CHEMISTRY
- Repeatability and Reproducibility in Proteomic Identifications by Liquid Chromatography−Tandem Mass Spectrometry
- (2009) David L. Tabb et al. JOURNAL OF PROTEOME RESEARCH
- Interlaboratory Study Characterizing a Yeast Performance Standard for Benchmarking LC-MS Platform Performance
- (2009) Amanda G. Paulovich et al. MOLECULAR & CELLULAR PROTEOMICS
- Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma
- (2009) Terri A Addona et al. NATURE BIOTECHNOLOGY
- Investigating the correspondence between transcriptomic and proteomic expression profiles using coupled cluster models
- (2008) Simon Rogers et al. BIOINFORMATICS
- Quantification of Thyroglobulin, a Low-Abundance Serum Protein, by Immunoaffinity Peptide Enrichment and Tandem Mass Spectrometry
- (2008) A. N. Hoofnagle et al. CLINICAL CHEMISTRY
- Mass Spectrometry Based Targeted Protein Quantification: Methods and Applications
- (2008) Sheng Pan et al. JOURNAL OF PROTEOME RESEARCH
- Selected reaction monitoring for quantitative proteomics: a tutorial
- (2008) Vinzenz Lange et al. Molecular Systems Biology
- Multi-University Research Teams: Shifting Impact, Geography, and Stratification in Science
- (2008) B. F. Jones et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search